A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age
Clinical trial NCT00834041 · COMPLETED
Trial details
- NCT number
- NCT00834041
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-01-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.